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Introduction
The number of neurons and glia that form during the
development of the CNS is controlled by the coordination of
extracellular factors, cell to cell interactions and intrinsic
mechanisms that regulate neuroepithelial cell proliferation,
differentiation and survival (Edlund and Jessell, 1999).
Manipulating neural stem cells (NSC) is an experimental
approach to determine the effects of extrinsic factors and of
signalling pathways during development (Rajan et al., 2003;
Sinor and Lillien, 2004). The differentiation of murine
embryonic olfactory bulb stem cells (OBSCs) requires insulin-
like growth factor I (IGF-I) both in culture and in vivo and, in
addition, IGF-I and (pro)insulin promote OBSC proliferation
(Vicario-Abejón et al., 2003). IGF-I has also been reported to
regulate the proliferation and differentiation of neuroepithelial
cells in other regions of the brain (Brooker et al., 2000;
Arsenijevic et al., 2001; Hodge et al., 2004; Hsieh et al., 2004).
The respective membrane receptors through which (pro)insulin
and IGF-I transmit their signals – the insulin and IGF-I
receptor – are widely expressed in the CNS and are found in
the olfactory bulb (OB) and OBSCs (De Pablo and de la Rosa,
1995; Varela-Nieto et al., 2003; Vicario-Abejón et al., 2003;
Bondy and Cheng, 2004). The intracellular signalling
pathways activated upon insulin/IGF-I receptor stimulation
include the phosphoinositide 3-kinase (PI 3-kinase) pathway
and its downstream target, the serine/threonine kinase Akt
(Taniguchi et al., 2006). The PI 3-kinase is made up of a
regulatory (p85) and a catalytic (p110) subunit. The p110-
knockout mice die at embryonic day (E) 9.5-10 showing CNS
defects, in part due to impaired cell division (Bi et al., 1999).
Accordingly, enhanced PI 3-kinase activation in the retina
augmented proliferation and interfered with cell death in such
a way that excessive growth of this tissue occurred during early
development (Pimentel et al., 2002). Stimulation of Akt by
exogenous insulin also decreased apoptosis in the proliferating
retina (Diaz et al., 1999). Three isoforms of Akt (Akt1, Akt2
and Akt3, also known as PKB, , and , respectively) have
been found in mammals, and recent reports indicate that Akt1
and Akt3 influence brain size and the number of cells in the
brain (Easton et al., 2005; Tschopp et al., 2005).
Akt is activated by the association of phosphorylated
phosphoinositide (PI) generated in reactions catalysed by PI
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3-kinase. For complete activation, Akt must be translocated to
the plasma membrane where it is phosphorylated at Thr308 and
Ser473 (Bayascas and Alessi, 2005; Song et al., 2005). Akt
activity is negatively regulated by molecules that antagonise PI
3-kinase, such as the dual lipid and protein phosphatase PTEN
(Cantley and Neel, 1999; Simpson and Parsons, 2001). There
is evidence that PTEN regulates multiple steps in CNS
development (for reviews, see Li et al., 2003a; Stiles et al., 2004).
Using a nestin-promoter-driven Cre transgene, PTEN has been
deleted in neural precursor cells, producing an enlargement of
the brain, possibly due to the enhanced proliferation and survival
of neuroepithelial cells (Groszer et al., 2001; Groszer et al.,
2006). It is also thought that PTEN regulates neuronal
positioning, migration and cell size (Backman et al., 2001; Kwon
et al., 2001; Li et al., 2002; Marino et al., 2002; Li et al., 2003a;
Li et al., 2003b), as well as neuronal dendritogenesis and
Bergman glia differentiation (Lachyankar et al., 2000; Musatov
et al., 2004; Yue et al., 2005; Jaworski et al., 2005). Thus, it
appears that the regulation and function of PTEN depends on the
cell type and the stage of development. Furthermore, the PI 3-
kinase–PTEN–Akt signalling pathway appears to be implicated
in multiple processes that remain to be fully analysed in defined
neural systems. Here, we have examined whether this signalling
pathway mediates the effects of IGF-I on OBSCs and on the OB
in vivo. Our results indicate that this pathway plays a prominent
role in regulating the number of OBSCs, as well as their
differentiation into neurons and astrocytes.
Results
IGF-I stimulates the PI 3-kinase–Akt pathway in cultured
OB neural stem cells and in the OB in vivo
We previously showed that IGF-I promotes the proliferation
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and differentiation of cultured OBSCs, and that neuronal and
glial development is altered in the OB of Igf-I knockout mice
(Pichel et al., 2003; Vicario-Abejón et al., 2003). To elucidate
the biochemical pathways that may mediate the effects of IGF-
I, we determined the levels of Akt phosphorylated on residues
Ser473 and Thr308 (P-AktSer473 and P-AktThr308, respectively)
and phosphorylated Erk1/2 (P-Erk1/2) in extracts from IGF-I-
stimulated OBSCs cells (Fig. 1) and from the OB of E16.5-
E18.5 Igf-I–/– and Igf-I+/+ mice (Fig. 2). Treatment of cultured
cells with 100 ng/ml IGF-I produced a marked increase in
the levels of P-AktSer473 and P-AktThr308 during OBSC
proliferation and differentiation when compared with those
found in control cultures. The increase in P-Akt levels was
observed 5 minutes after addition of IGF-1 and lasted for
at least 24 hours (data not shown). By contrast, Erk1/2 was
highly phosphorylated in basal control conditions and
phosphorylation was not stimulated further by IGF-I. Akt
phosphorylation was IGF-I dependent because a 50%
reduction was observed in P-AktSer473 levels in the OB
obtained from E16.5-E18.5 Igf-I–/– mice compared with those
of Igf-I+/+ mice (Fig. 2). The absence of IGF-I did not change
Fig. 1. IGF-I stimulates Akt-phosphorylation in cultured OB neural
stem cells. OBSCs derived from E14.5 embryos were treated with
100 ng/ml IGF-I or with BSA for 30 minutes in conditions of
proliferation (presence of EGF and FGF-2) and differentiation (in the
absence of mitogens). After lysing the cultured cells, proteins were
analysed by immunoblotting with specific antibodies against P-
AktSer473, P-AktThr308, Akt, P-Erk1/2 and Erk1/2. The very low basal
levels of P-Akt were markedly increased by the presence of IGF-I
and maintained for up to 24 hours (not shown). Similar results were
obtained in samples from six experiments.
Fig. 2. Absence of endogenous IGF-I reduces P-Akt levels in the OB
in vivo. (A) OBs from E16.5-E18.5 Igf-I+/+ and Igf-I–/– mouse
embryos from the same litters were homogenised and the proteins
were analysed by immunoblotting using specific antibodies against
P-AktSer473 and Akt. (B) The optical density of the specific bands in
immunoblotted membranes was measured by densitometry using
Quantity One software. The levels of P-Akt were normalised to the
levels of Akt and expressed in arbitrary units. (*P<0.05; Igf-I+/+, n=8;
Igf-I–/–, n=9.)
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the pattern of TdT-mediated dUTP nick-end labelling
(TUNEL) staining in the E18.5 OB (data not shown).
PTEN overexpression impairs OBSC differentiation into
neurons and astrocytes as well as basal levels of P-Akt
IGF-I appears to be an important factor in controlling P-Akt
levels in the developing OB cells. To study the influence of
the PI 3-kinase–P-Akt pathway in the proliferation and
differentiation of neural stem cells, OBSCs were infected with
a retroviral vector expressing PTEN-GFP (Fig. 3). On average,
at least 80% of OBSCs were infected with the control GFP
vector (Fig. 3B,D,F) and these cells proliferated in the same
manner as the mock-infected cells (Fig. 3A,C,E). A similar
high infection efficiency was obtained when cells were
infected with the PTEN-GFP and the PTEN-C/S-GFP vector,
and PTEN overexpression was confirmed by immunoblotting
with an antibody against the HA tag or PTEN (Fig. 3G). The
relative levels of PTEN-GFP and PTEN-C/S-GFP were
increased 2.2-fold and 3.1-fold, respectively, relative to those
of endogenous PTEN (Fig. 3G,H). Upon mitogen removal, the
infected cells differentiated into neuronal class III -tubulin
(TuJ1)-positive neurons (Fig. 3I-K), glial fibrillary acidic
protein (GFAP)-positive astrocytes (Fig. 3L-N), and
oligodendrocyte marker O4 (O4)-positive oligodendrocytes
(Fig. 3O-Q).
We analysed the effects of PTEN overexpression on
OBSC proliferation and differentiation by immunolabelling
proliferative cells with 5-bromo-2-deoxyuridine (BrdU),
neurons with TuJ1, astrocytes with GFAP and
oligodendrocytes with O4 (Fig. 4). Since the standard culture
medium contained a high concentration of insulin (10 g/ml)
that might counteract the effects of PTEN overexpression,
these analyses were performed in cells cultured with and
without insulin/IGF-I. In a previous study (Vicario-Abejón et
al., 2003) we had demonstrated that this concentration of
insulin promoted differentiation to a similar extent as 100
ng/ml of IGF-I and, thus, we have used these concentrations of
either factor interchangeably. The total number of GFP-
positive cells and the percentage of BrdU-GFP double-labelled
cells was similar in the PTEN-infected cultures and in the GFP-
infected cultures, both with or without insulin (Fig. 4A). By
contrast, PTEN overexpression produced a significant decrease
in the percentages of TuJ1-positive (46%) and GFAP-positive
(35%) cells, in insulin-free cultures compared with cultures
exposed to insulin (Fig. 4B,C). The percentage of
Fig. 3. Infection of OBSCs with retroviral vectors expressing PTEN
and GFP. (A-F) OBSCs derived from E14.5 embryos were infected
with a retroviral construct expressing GFP (B,D,F) or they were
mocked infected (A,C,E). The GFP-infected cells (B) proliferated
with the same pattern as mocked infected ones (A). On average, 90%
of the OBSCs were infected with the GFP-expressing vector as
determined by flow cytometry (E,F). No detectable GFP was
observed in the mock-infected cells (C,E). (G) OBSC cultures were
infected in parallel with a vector expressing PTEN-GFP or with a
vector expressing GFP. Immunoblotting with an antibody against the
HA-tag confirmed that PTEN was overexpressed in infected cells.
The average relative levels of PTEN were 2.2-fold greater in the
PTEN-GFP infected cells than in control GFP cells (n=3). (H) OBSC
cultures were infected in parallel with a vector expressing PTEN-
C/S-GFP or with a vector expressing GFP. Immunoblotting with an
antibody against PTEN confirmed that mutant PTEN was
overexpressed in infected cells. PTEN-C/S-GFP levels were 3.1-fold
those of endogenous PTEN (n=2). (I-Q). GFP infected cells were
induced to differentiate by mitogen withdrawal, they were then fixed
48 hours later and the co-expression of TuJ1 and GFP (I-K) or GFAP
and GFP (L-N) or O4 and GFP (O-Q) was evaluated in the cultures
by double immunostaining with specific antibodies. Bar, 30 m.
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oligodendrocytes in the insulin/IGF-I-free culture conditions
was increased (40%) by PTEN overexpression although the
increase was not statistically significant (Fig. 4D). To
determine whether the reduction in the number of neurons and
astrocytes following PTEN overexpression was due to
an increase in cell death, cells were stained by using the
TUNEL method. In differentiating OBSC cultures, PTEN
overexpression did not augment the percentage of TUNEL-
positive cells, nor did it decrease the total number of cells
growing in the presence of insulin or IGF-I, or in the absence
of these factors (Fig. 4E and data not shown). These results
suggest that a moderate increase in PTEN levels in OBCS
impairs differentiation into neurons and astrocytes without
significantly affecting cell survival.
Since PTEN negatively regulates the PI 3-kinase–Akt
pathway by dephosphorylating phosphatidylinositol (3,4,5)-
trisphosphate [PtdIns(3,4,5)P3] (Waite and Eng, 2002), we
determined the consequence of PTEN overexpression on Akt
phosphorylation in control cultures and cultures stimulated
with 100 ng/ml IGF-I (Fig. 5A). Basal P-Akt levels were
reduced by 58.4% in cells infected with the PTEN-GFP
construct, although stimulation with IGF-I resulted in a
similar Akt phosphorylation in both PTEN-GFP and control
cells. PTEN thus appeared to regulate basal levels of P-
AktSer473 and P-AktThr308, whereas overexpression of PTEN
did not modify basal or IGF-I-stimulated levels of P-Erk1/2
Journal of Cell Science 119 (13)
Fig. 4. PTEN overexpression reduces the differentiation of OBSCs
into neurons and astrocytes. OBSC cultures were infected in parallel
with a vector expressing PTEN-GFP or with a vector expressing GFP
alone. Three days later, the cells were passaged and cultured for 2-3
days in conditions of proliferation (with EGF and FGF-2) or
differentiation (in the absence of mitogens), in the presence or
absence of insulin/IGF-I (10 g/ml of insulin had similar potency as
100 ng/ml IGF-I to stimulate OBSC differentiation). (A) Proliferative
cultures were incubated with 5 M BrdU for 22 hours before
fixation. (A-D) The proportions of TuJ1-positive, GFAP-positive and
O4-positive cells co-labelled for GFP were calculated. The data
obtained in PTEN-GFP infected cultures was expressed as the
percentage of the data obtained in GFP-infected cultures, which were
considered to be 100% (dotted line). The results are expressed as the
average ± s.e.m. of data of 4-8 cultures from 2-5 experiments.
Statistical analysis comparing values obtained with insulin (+INS)
and without insulin (–INS) was performed using Student’s t-test.
PTEN overexpression significantly reduced the proportions of TuJ1-
positive and GFAP-positive cells in the absence of insulin (*P<0.05)
whereas the proportion of O4-positive cells showed a tendency to
increase. (E) The proportions of TUNEL-positive cells were not
affected by PTEN overexpression under any of the growth conditions
tested.
Fig. 5. PTEN overexpression reduces basal levels of Akt
phosphorylation at residues Ser473 and Thr308. (A) OBSCs derived
from E14.5 CD1 embryos were infected with the PTEN-GFP or GFP
construct and they were then stimulated with 100 ng/ml IGF-I or
BSA (basal level) for 30 minutes under conditions of differentiation.
Whereas IGF-I greatly stimulated P-Akt levels in both PTEN-GFP-
and GFP-infected cells, the overexpression of PTEN reduced P-Akt
basal levels. Similar results were obtained in samples from three
experiments. (B) OBSCs derived from E14.5. Igf-I–/– embryos were
infected with the PTEN-GFP or GFP construct and were then
stimulated with 10-100 ng/ml IGF-I or BSA (basal level) for 30
minutes under conditions of differentiation. The overexpression of
PTEN reduced IGF-I-stimulated P-Akt levels only when 10 ng/ml of
the growth factor was used. In B, to observe the signals
corresponding to P-Akt basal levels, the films were developed for a
long time, saturating for signals corresponding to IGF-I-stimulated
P-Akt. For this reason, they are presented separately. Similar results
were obtained in samples from two experiments.
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(data not shown). To further assess whether overexpression of
PTEN partially inhibits Akt phosphorylation by IGF-I,
stimulation experiments were performed by using low
concentrations of the growth factor on OBSC-differentiating
cultures prepared from Igf-I knockout mice. Ten ng/ml IGF-I
increased P-AktSer473 levels and this effect was partially
abrogated (46% reduction, average data from two
experiments) by overexpression of PTEN; only minimal
reductions in P-AktSer473 levels occurred when higher
concentrations (20-100 ng/ml) of IGF-I were used in Igf-I
knockout cells that overexpressed PTEN (Fig. 5B).
Overexpression of a PTEN mutant (PTEN-C/S-GFP)
promotes neuron and astrocyte differentiation
To corroborate the implication of PTEN in neuronal and
astrocyte differentiation, a catalytically inactive mutant
(PTEN-C/S-GFP) was overexpressed in Igf-I knockout
OBSCs. This mutant previously showed markedly reduced in
vitro lipid phosphatase activity (Lacalle et al., 2004). PTEN-
C/S-GFP overexpression caused an ~20% increase in the
number of TuJ1-positive neurons and of GFAP-positive
astrocytes in OBSC cultures differentiating in the presence of
IGF-I (Fig. 6A,B). In OBSC cultures differentiating in the
absence of IGF-I (and of insulin), however, overexpression of
the catalytically inactive mutant PTEN produced an increase
of 52% and a 42% (P<0.05) of TuJ1-positive cells (Fig. 6A)
and GFAP-positive cells (Fig. 6B), respectively, further
indicating a role of the phosphatase PTEN in neuron and
astrocyte differentiation. PTEN-C/S-GFP overexpression
produced no change in P-Akt levels in OBSC extracts (data not
shown), as has been reported for Jurkat cells (Lacalle et al.,
2004).
Effects of PI 3-kinase inhibition on OBSC number and
differentiation
Since a moderate increase of PTEN levels in the cells caused
a reduction in the basal levels of P-Akt and OBSC
differentiation into neurons and astrocytes, we studied the
consequences of further inhibiting the PI 3-kinase activity on
these processes. Exposing cultures to the PI 3-kinase inhibitor
LY294002 (30 M) (Vanhaesebroeck et al., 2005) in the
presence of IGF-I provoked a marked reduction in the levels
of P-AktSer473 after 24 hours, during both OBSC proliferation
(Fig. 7A) and differentiation (Fig. 8A). The P-AktThr308 levels
were only moderately reduced by LY294002 (Fig. 7A, Fig. 8A)
and, although P-Erk1/2 was not significantly affected in
proliferative OBSCs (Fig. 7A), the levels of P-Erk1 (but not P-
Erk2) were slightly diminished in LY294002-treated cells
undergoing differentiation (Fig. 8A). We then examined the
effects of downregulating PI 3-kinase activity on the number
of proliferative OBSCs (Fig. 7) and on the production of
OBSC-derived neurons and astrocytes (Fig. 8). LY294002
inhibition of Akt phosphorylation produced decreases of 56%
(P<0.01) and 46% (P<0.001) in the proportion of BrdU-
positive cells growing in the presence of IGF-I or its absence
(BSA added instead of IGF-I), respectively, compared with
cultures maintained with the vehicle (DMSO added) (Fig.
7B,E,F). The effect of LY294002 was partially reverted by
IGF-I; the percentage of BrdU-positive-cells was 64% higher
(P<0.01) than that of cells exposed to LY294002 in the
presence of BSA (basal levels, Fig. 7B). Total cell number was
not significantly affected by LY294002 in basal cultures but it
was reduced by 27% (P<0.05) in the presence of IGF-I (Fig.
7C,E-H). Indeed, addition of LY294002 to the cultures caused
a 47.6% (P<0.05) and a twofold increase (P<0.001) in the
proportion of TUNEL-positive cells in the presence of BSA
and IGF-I, respectively (Fig. 7D,G,H). IGF-I counteracted the
effect of LY294002 on cell death because the percentage of
TUNEL-positive cells in the presence of IGF-I was 50%
(P<0.05) lower than with BSA. IGF-I thus partially protected
cells from LY294002-induced cell death under conditions in
which P-Akt levels were low.
PI 3-kinase inhibition by LY294002 also affected OBSC
differentiation. Exposure to LY294002 produced a 58% (non
significant) and 51% (P<0.01) reduction in the number of
TuJ1-positive cells in the presence of BSA and IGF-I,
respectively (Fig. 8B,E,F). After exposure to LY294002, the
number of TuJ1-positive cells was approximately fivefold
greater (P<0.001) in the presence of IGF-I than with BSA,
further evidence that IGF-I partially protects the cells from the
effects of LY294002 when P-Akt levels were reduced. Similar
responses were observed in the number of astrocytes in
differentiating OBSC cultures (Fig. 8C,G,H). LY294002
produced a 40% (P<0.001) and 43% (P<0.001) decrease in the
percentage of GFAP-positive cells in the presence of BSA and
IGF-I, respectively. However, the percentage of IGF-I-treated
GFAP-positive cells was twofold (P<0.001) in the presence of
IGF-I than compared with control cells treated with BSA.
Astrocytes cultured with IGF-I together with LY294002 had
less processes than cells growing in IGF-I together with DMSO
(Fig. 8G,H). In the absence of IGF-I, the percentage of
TUNEL-positive cells was similar in cultures treated with or
without LY294002, whereas in the presence of IGF-I,
LY294002 produced in a 27% increase (P<0.05) in these cells
Fig. 6. Overexpression of a catalytically inactive mutant form of
PTEN promotes neuron and astrocyte differentiation. OBSC cultures
from Igf-I–/– embryos were infected in parallel with a vector
expressing PTEN-C/S-GFP or with a vector expressing GFP alone.
Three days later, the cells were passaged and cultured for 2-3 days in
conditions of differentiation (in the absence of mitogens), in the
presence or absence of 100 ng/ml IGF-I. (A,B) Of the total number
of GFP-positive cells, the proportion that co-expressed TuJ1 or
GFAP was calculated. The data obtained in PTEN-C/S-GFP-infected
cultures was expressed as the percentage of the data obtained in
GFP-infected cultures that were considered to be 100% (dotted line).
The results are expressed as the average ± s.e.m. of data of 4-8
cultures from two experiments. PTEN-C/S-GFP overexpression
increased the proportions of TuJ1-positive and GFAP-positive cells
by 52% and 42%, respectively, in the absence of IGF-I. (*P<0.05;
Student’s t-test.)
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(Fig. 8D,I,J). In accordance with the earlier data, the proportion
of TUNEL-positive cells induced by LY294002 in the presence
of IGF-I was nevertheless significantly lower (P<0.01) than in
BSA. Overall, these results demonstrate an important role of
the PI 3-kinase–Akt pathway during the differentiation of
OBSCs, concurring with a minor effect on cell survival.
Discussion
Neuronal differentiation and allocation of neurons to cell layers
in the OB requires IGF-I in vivo. Similarly, proliferation and
differentiation of OBSCs in culture depends on (pro)insulin
and IGF-I (Vicario-Abejón et al., 2003). We have studied the
biochemical pathways that are activated by IGF-I in the
OBSCs, and the role of the PI 3-kinase–Akt pathway in
regulating OBSC number and differentiation. We show that
in the absence of insulin or IGF-I, the basal levels of
phosphorylated Akt in cultured OBSCs are very low and that
IGF-I greatly stimulated Akt phosphorylation, at both the
regulatory Ser473 residue and the catalytic Thr308 residue.
More importantly in physiological terms, IGF-I is needed to
maintain normal levels of P-Akt in the OB in vivo. By contrast,
high basal levels of P-Erk1/2 were detected and further
stimulation by IGF-I did not alter the phosphorylation of this
kinase. Moderate overexpression of PTEN in the OBSC
diminished the basal phosphorylation of Akt as well as that
stimulated by IGF-I (only by 10 ng/ml). Moreover, PTEN
overexpression impaired neuronal and astrocyte differentiation
without significantly affecting cell proliferation or cell death.
Accordingly, overexpression of a catalytically inactive mutant
PTEN promoted OBSC differentiation. Pharmacological
inhibition of PI 3-kinase by LY294002 blocked the effects of
IGF-I on Akt phosphorylation. Likewise, the proliferation and
survival of OBSC was impaired, and neuron and astrocyte
differentiation was diminished. Thus, whereas a reduction in
basal P-Akt affects OBSC differentiation, inhibition of IGF-I-
induced PI 3-kinase–P-Akt activation blocks proliferation and
survival.
The marked effect of IGF-1 on Akt phosphorylation and the
failure to activate Erk1/2 in the OBSCs is in contrast to the
stimulation of the Erk1/2 pathway by IGF-I in adult
hippocampal stem cells (HPSC). However, in contrast to the
high basal P-Erk1/2 levels found in embryonic OBSCs, adult
HPSC display low levels of P-Erk1/2 (Aberg et al., 2003). This
difference may partially account for the relatively higher rate
of proliferation of embryonic NSC when compared with adult
NSC (Gritti et al., 2002; Aberg et al., 2003; Vicario-Abejón et
al., 2003; Yusta-Boyo et al., 2004). Therefore, we focused our
attention on the PI 3-kinase–Akt pathway.
Although the activated PI 3-kinase–Akt pathway plays a
major role in preventing cell death in many cell types (Brazil et
al., 2004; Song et al., 2005), our results show that this pathway
also increases OBSC proliferation. Moreover, both the
prevention of cell death and the increase in proliferation, lead
to an increase in the number of stem cells in this system. The
PI 3-kinase–Akt pathway has also been shown to influence self-
renewal in cortical stem and/or precursor cells overexpressing
Akt-1 (Sinor and Lillien, 2004) as well as in retinal precursors
overexpressing p65, an activated form of the regulatory subunit
of PI 3-kinase (Pimentel et al., 2002). Indeed, defects in neural
proliferation have been observed in mice carrying a deletion in
the p110 subunit of PI 3-kinase (Bi et al., 1999). We found
that the PI 3-kinase–P-Akt pathway is involved in OBSC
differentiation into neurons and astrocytes, with a minimal
influence on cell death. The reduction in P-Akt levels in the OB
Journal of Cell Science 119 (13)
Fig. 7. Effects of PI 3-kinase inhibition on OBSC proliferation, cell
death and OBSC number. Cultures of OBSCs derived from E14.5
embryos were plated for 48 hours in conditions of proliferation, in
the presence or absence of 100 ng/ml IGF-I, and they were treated
with 30 M LY294002 for the last 24 hours. (A) P-AktSer473
phosphorylation was strongly inhibited by LY294002 while the
reduction of P-AktThr308 was moderate, without any change in the
levels of P-Erk1/2. One representative immunoblot out of three
experiments is shown. (B,E,F) Proliferating cultures were incubated
with 5 M BrdU for 22 hours before fixation. The addition of
LY294002 significantly decreased the percentages of BrdU-positive
cells in the presence of BSA or IGF-I. (C) LY294002 caused a
significant reduction in the total number of cells growing in IGF-I
and augmented the percentage of TUNEL-positive cells in the
presence of BSA or IGF-I (D,G,H). Results are the average ± s.e.m.
from 4-6 cultures. Statistical analysis was performed using Student’s
t test. (*P<0.05 **P<0.01.) Bar, 30 m.
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of E16.5-E18.5 IGF-I knockout mice, concomitant with
impaired neuronal and glial differentiation further supports a
role of Akt in neuronal differentiation within the OB in vivo
(Pichel et al., 2003; Vicario-Abejón et al., 2003). Akt
overexpression was recently shown to promote the generation
of NG2-positive oligodendrocyte precursors but not the
generation of neuron or astrocyte precursors (Sinor and Lillien,
2004). However, by inhibiting PI 3-kinase activity and Akt
phosphorylation, we found that the PI 3-kinase–Akt pathway
did regulate neuron and astrocyte differentiation. Further, our
findings are in agreement with those of Easton et al. (Easton et
al., 2005) and Tschopp et al. (Tschopp et al., 2005), who
recently reported a reduction in brain size and in the number of
brain cells in Akt1 and Akt3 knockout mice. This emphasises
the important role of Akt activation in establishing the final
composition of the nervous system.
LY294002 produced a strong decrease in the levels of IGF-
I-stimulated P-AktSer473, as well as a significant increase in cell
death during OBSC proliferation and inhibition of OBSC
differentiation. Inhibition of the PI 3-kinase pathway in the
presence of IGF-I, however, did not increase the number of
TUNEL-positive cells nor reduce the number of BrdU-positive
cells, neurons or astrocytes beyond the control (BSA) levels.
This could be due to residual Akt kinase activity because
LY294002 did not completely block phosphorylation at Thr308
(our results) (Brodbeck et al., 1999; Sarbassov et al., 2005).
Alternatively, other biochemical pathways stimulated by IGF-
I or other growth factors produced by the OBSCs may be
involved and they may affect the processes observed. High
concentrations of LY294002 also slightly reduced the levels of
P-Erk1, as we observed in differentiating cells, suggesting a
degree of cross-talk between these pathways in OBSCs.
Preliminary experiments in which Erk1/2 is blocked by the
MAP kinase inhibitor UO126 indicate a contribution of this
pathway to regulate proliferation of OBSCs. It is also known
that there are downstream targets of PI 3-kinase, apart from
Akt, which can influence cell cycle kinetics and cell migration
(García et al., 2006).
IGF-I is a very potent stimulus for the OBSCs as the effects
of overexpressing the phosphatase PTEN were completely
blocked by 100 ng/ml IGF-I or M concentrations of insulin.
In fact, whereas PTEN overexpression reduced basal P-Akt
levels, it only affected the levels of IGF-I-stimulated P-Akt at
low concentration of IGF-I (10 ng/ml). These findings are in
accordance with data from other systems (Myers et al., 1998;
Lacalle et al., 2004; Seminario et al., 2004), and support the
concept that the main role of PTEN is in regulating the basal
levels of PtdIns(3,4,5)P3 and thus, of phosphorylated Akt. The
reduction in basal P-Akt appears to result in the specific effects
of high PTEN expression, that is the decrease in OBSC
Fig. 8. Effects of PI 3-kinase inhibition by LY294002 on OBSC neuronal and astrocyte differentiation. OBSCs derived from E14.5 embryos
were cultured for 48 hours in differentiation conditions in the presence or absence of 100 ng/ml IGF-I, and they were treated with 30 M
LY294002 for the last 24 hours. (A) P-AktSer473 phosphorylation was strongly inhibited by LY294002, whereas the reduction of P-AktThr308 was
moderate. LY294002 produced a small effect on the levels of P-Erk1 (but not on P-Erk2) only in conditions of differentiation. One
representative immunoblot out of three experiments is shown. (B) The addition of LY294002 significantly decreased the percentages of TuJ-1-
positive cells in the presence of IGF-I and it significantly decreased the percentages of GFAP-positive cells in the presence of BSA and IGF-I
(C). (D) Exposure to LY294002 produced a slight but significant increase in the number of TUNEL-positive cells, only in the presence of IGF-
I. The results are the average ± s.e.m. from 4-6 cultures. Representative fields of neuronal (TuJ-1; E,F) and astrocyte (GFAP; G,H)
morphologies are shown. The number of TUNEL-positive cells was only slightly higher in cultures treated with LY294002 (I,J). Statistical
analysis was performed using Student’s t test. (*P<0.05, **P<0.01.) Bar, 25 m.
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differentiation into neurons and astrocytes in the absence of
insulin or IGF-I. Accordingly, PTEN overexpression in PC12
cells inhibits neuronal differentiation; a reduction in nerve
growth factor (NGF) stimulated levels of both P-Akt and P-
Erk1/2 was also reported (Musatov et al., 2004). By contrast,
PTEN overexpression in neuroblastoma cells was seen to
decrease the stimulatory effect of IGF-I on Akt
phosphorylation without affecting the Erk1/2 pathway (van
Golen et al., 2001). Thus PTEN appears to influence neuronal
and astrocyte differentiation, as supported by our studies with
a catalytically inactive PTEN mutant and in a recent study
indicating that PTEN is involved in the differentiation of
cerebellar Bergmann glia cells (Yue et al., 2005). The decrease
in the number of neurons and astrocytes in OBSCs
overexpressing PTEN (growing in the absence of insulin or
IGF-I) was concomitant with a tendency to augment the
number of oligodendrocytes. Hence, this cell lineage may well
depend on additional signalling pathways for differentiation, a
phenomenon that ought to be explored. Indeed, we have
previously shown that IGF-I and BDNF collaborate to promote
oligodendrocyte differentiation (Vicario-Abejón et al., 2003).
We would have expected to observe an increase in P-Akt levels
in cultures that overexpress PTEN-C/S-GFP concomitant with
the increase in OBSC differentiation. However, no putative rise
in P-Akt levels was observed in a single time-point studied,
according to the effects of the mutant PTEN-C/S-GFP seen in
linfoid cells (Lacalle et al., 2004). Whether PTEN-C/S-GFP
overexpression can produce a transient change in Akt
phosphorylation that is undetectable by the methods used here
remains to be explored.
PTEN knockout mice do not display any changes in neuron
or astrocyte numbers (Groszer et al., 2001). We found that
following PTEN overexpression, neuronal and glia
differentiation was only inhibited in the absence of insulin.
Thus, the effects of PTEN deletion on differentiation might be
masked by the presence of insulin in the culture medium
(Groszer et al., 2001) that maintained high levels of P-Akt in
the knockout or wild-type cells. Indeed, PI 3-kinase–Akt has
recently been proposed to participate in the control of neuronal
dendritogenesis and arborisation, modulated by upstream Ras
and balanced by PTEN (Jaworski et al., 2005; Kumar et al.,
2005). In these studies, mTOR appears to be the downstream
target of PI 3-kinase–Akt and it has been proposed that mTOR
is a convergence point for multiple signalling pathways that
regulate neuronal development.
Under our experimental conditions, the moderate increase in
the levels of PTEN (2.2-fold) did not affect the proliferation of
OBSCs in the presence of fibroblast growth factor 2 (FGF-2)
and epidermal growth factor (EGF). These mitogens activate
the Erk1/2 pathway (data not shown) (Kessaris et al., 2004) and
could then counteract the putative effects of PTEN phosphatase
activity on proliferation. Accordingly, we cannot rule out a role
for PTEN in maintaining the homeostasis of cell proliferation
in the OB in vivo. Indeed, deletion of PTEN provokes changes
in proliferation in other systems, producing more proliferative
cells in the ventricular zone of the telencephalon at E14.5
(Groszer et al., 2001; Groszer et al., 2006) and subventricular
zone (SVZ) neurospheres (Li et al., 2002). The loss of PTEN
also increases astrocyte proliferation (Fraser et al., 2004) and
it reduces the number of proliferative cells in the E15.5
cerebellum (Marino et al., 2002) and in the SVZ (Li et al.,
2002). These discordant results probably reflect the different
influences of PTEN on neural proliferation, or the cell-type-
and developmental-stage-dependent nature of its effects. This
same conclusion might apply to the role of PTEN in cell death.
Fewer TUNEL-positive cells have been reported in the cortical
ventricular zone (Groszer et al., 2001) and cerebellum (Marino
et al., 2002) of PTEN knockout mice, and in the SVZ of
heterozygous PTEN mice (Li et al., 2002). However a GFAP-
Cre controlled deletion of PTEN did not affect cell death in the
hippocampus and cerebellum (Backman et al., 2001). The
influence of PTEN on cell death may vary in the presence of
a toxic insult, because hippocampal neurons overexpressing
PTEN were more sensitive to cell death triggered by excitatory
amino acids, and PTEN+/– and PTEN–/– neurons were more
resistant to cell death than wild-type neurons (Gary and
Mattson, 2002; Li et al., 2002; Yue et al., 2005).
Overexpression of PTEN, nevertheless, did not induce cell
death in OBSCs in the absence of a toxic insult.
Together, our findings suggest an important role for the PI
3-kinase–Akt pathway in controlling neural stem/precursor cell
number, and their differentiation into neurons and astrocytes.
They also indicate that these processes are differentially
regulated by distinct levels of P-Akt. In this respect, neuronal
and astrocyte differentiation is more sensitive to reduced P-Akt
activity than neural stem cell proliferation or cell death.
Through the fine modulation of P-Akt levels, in collaboration
with additional signalling pathways, IGF-I and PTEN regulate
cell development in the OB.
Materials and Methods
Neural stem cell cultures
Tissue culture reagents were purchased from Gibco-Life Technologies (Carlsbad,
CA) and Sigma (St Louis, MO), whereas EGF, FGF-2 and brain-derived
neurotrophic factor (BDNF) were obtained from PeproTech (Rocky Hill, NJ).
Human insulin was a kind gift of Eli Lilly (Indianapolis, IN) or was purchased from
Sigma. Neural stem cells (NSC) were prepared from the olfactory bulb (OB) of
E14.5 embryos obtained from CD1 mice or from Igf-I knockout mice (Liu et al.,
1993; Vicario-Abejón et al., 2003); the day on which a vaginal plug was detected
being considered E0.5. Genotypes were determined by PCR using two primer sets
specific either for the Igf-I gene (sense primer: 5-GTCTAACACCAGCCC-
ATTCTGATT-3, antisense primer: 5-GACTCGATTTCACCCACTCGATCG-3)
yielding a 250 bp product, or for the neomycin gene (sense primer: 5-GCT-
TGGGTGGAGAGGCTATTC-3, antisense primer: 5-CAAGGTGAGATGACAG-
GAGAT-3) yielding a 284 bp product. PCR conditions were: denaturing at 94°C
for 30 seconds, annealing at 58°C for 45 seconds, and extension at 72°C for 45
seconds for 35 cycles. The product was detected by agarose gel electrophoresis. All
animal care was in accordance with European Union guidelines.
After removing the brain from the skull, the OB was dissected and mechanically
disaggregated. The resulting cells were resuspended in DMEMF12/N2 medium,
made from Dulbecco’s modified Eagle’s medium (DMEM) nutrient mixture F12
(F12) containing insulin, apotransferrin, putrescine, progesterone, sodium selenite
(N2), and then plated on uncoated tissue culture dishes at a density of 3.5104
cells/cm2. FGF-2 and EGF (20 ng/ml each) were added daily to expand and passage
the proliferating precursor cell population (Vicario-Abejón et al., 2003).
Infection of NSC with retroviral vectors
Infection was performed using a Moloney murine leukaemia virus-based retroviral
vector (Mo-MLV). The retroviral construct pRV-IRES-GFP encodes an improved
variant of the Aequorea Victoria green fluorescent protein (GFP), and it was
obtained by cloning a SacII-NotI fragment of the pLZR-IRES-GFP vector into a
pRV plasmid. This GFP vector was used as a control in infection experiments. A
construct encoding the complete PTEN cDNA (1.2 kb) fused to a cDNA of the
hemaglutinine (HA) N-terminus was cloned into the pRV-IRES-GFP vector, and in
the resulting vector pRV–HA-PTEN-IRES-GFP (PTEN-GFP) PTEN expression
was under LTR viral control. The PTEN catalytically inactive mutant (PTEN-C/S-
GFP), described and characterised recently (Lacalle et al., 2004), was also cloned
into the pRV-IRES-GFP vector. This mutated form has no HA-tag but is also
recognised by the PTEN antibody used to detect the wild-type PTEN.
To infect CD1- or Igf-I–/–-derived NSC, proliferating cells (3.5106) were
resuspended in 500 l of viral supernatant (3-5106 IU/ml) and 500 l
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DMEMF12/N2 in the presence of 6 g/ml of polybrene, 20 ng/ml EGF and 20
ng/ml FGF-2. The optimum ratio of the number of cells to viral supernatant was
established in pilot experiments. The cell suspension was plated in multiwell plates
and centrifuged at 2000 g, 37°C for 1 hour. The cells were then collected, washed
and cultured at a density of 15,000-20,000 cells/cm2 and incubated in the presence
of EGF and FGF-2 (37°C, 5% CO2). The cells were passaged 3 days later and plated
for 2-3 days in four-well chamber slides in proliferation (5000-6000 cells/cm2, with
EGF and FGF-2) or differentiation conditions (100,000 cells/cm2 without mitogens)
to study the effects of PTEN-GFP and PTEN-C/S-GFP overexpression in NSC.
Proliferating cells were incubated with 5 M 5-bromo-2-deoxyuridine (BrdU,
Boehringer-Mannheim) for 20-22 hours prior to fixation with 4%
paraformaldehyde. Some cultures were mock-infected to test whether the protocol
produced changes in the patterns of NSC proliferation and differentiation. To
calculate the efficiency of infection, cells were harvested and analysed by flow
cytometry. The three retroviral constructs had similar infection titles tested in NIH3
3T3 cells and produced comparable percentages of infected NSC.
Incubation of NSC with LY294002
To study the effect of inhibiting PI 3-kinase on neural stem cells, cultures were
incubated with LY294002 (Calbiochem, La Jolla, CA). After passage, NSC cells
were plated in proliferation conditions (DMEMF12/N2 without insulin containing
20 ng/ml EGF and 20 ng/ml FGF-2) or differentiation conditions (without
mitogens). To these cultures, 100 ng/ml IGF-I or, as a control, 0.001% BSA were
added for 24 hours, and 5 or 30 M LY294002 (dissolved in DMSO) or 1-1.5%
DMSO were also added for an additional 24 hours. The cells were then fixed for
immunostaining and TUNEL assays, or lysed for western blot analysis.
Immunoblotting of extracts from cultured cells and OBs
Immunoblotting was performed on IGF-I-stimulated cultures, LY294002-treated
cultures, PTEN-GFP- and GFP-infected cultures, and on dissected mouse OBs. To
analyse the effect of IGF-I on the phosphorylation of Akt and Erk, cell cultures were
grown for 24-48 hours under conditions of proliferation or differentiation in the
absence of insulin, and they were then treated with BSA (control) or 10 to 100 ng/ml
IGF-I for 5 minutes to 24 hours. The cells cultured under these different conditions,
as well as OB tissue dissected out from E16.5-E18.5 mouse embryos from an Igf-
I knockout colony (Liu et al., 1993; Vicario-Abejón et al., 2003), were incubated in
lysis buffer [50 mM Tris HCl pH 7.4, 300 mM NaCl, 1% Triton X-100, 1 mM
EDTA, 1 mM Ortovanadate, 25 mM NaF, 4 mM sodium pyrophosphate and a
complete mini EDTA free protease inhibitor tablet (Roche)] for 20 minutes at 4°C.
The lysed cells were centrifuged at 20,000 g, 4°C for 15 minutes, and the
supernatant collected and stored at –20°C for further analysis by immunoblotting.
Protein extracts were fractionated by electrophoresis on 7.5% polyacrylamide gels
and transferred to nitrocellulose membranes. The membranes were treated with 2
mg/ml BSA, 1% Tween 20, PBS for 1 hour at room temperature (RT) , and then
incubated overnight at 4°C with primary antibodies against: PTEN (goat polyclonal
1:1000, St Cruz Biotechnology, CA or rabbit polyclonal 1:2000, Cell Signalling,
Beverley, MA), -tubulin (mouse monoclonal 1:10,000, Sigma), HA (mouse
monoclonal 1:200, St Cruz), P-AktSer437 (rabbit polyclonal 1:2000, Cell Signalling),
P-AktThr308 (rabbit polyclonal 1:2000, Cell Signalling), Akt1/2 (goat polyclonal
1:2000, St Cruz), P-Erk1/2 (rabbit polyclonal 1:2000, Cell Signalling) or Erk1/2
(mouse monoclonal 1:1000; Zymed, San Francisco, CA). After washing, the
membranes were incubated for 1 hour at RT with horseradish peroxidase (HRP)-
conjugated secondary antibodies and then incubated with the enhanced
chemilumiscence (ECL) reagent (Amersham).
Immunostaining of cultured cells
Cultured cells were fixed with 4% paraformaldehyde in 0.1 M phosphate buffer pH
7.4, for 25 minutes. Cells were incubated overnight at 4°C or RT with primary
antibodies against: -III-tubulin (TuJ1, rabbit polyclonal, 1:2000; Covance,
Berkeley, CA), GFAP (rabbit polyclonal, 1:1000; Dako, Glostrup, Denmark), O4
(mouse monoclonal IgM, 1:8, kindly shared by A. Rodríguez Peña, Instituto de
Investigaciones Biomédicas, Madrid), BrdU (mouse monoclonal, 1:1000; the
Developmental Studies Hybridoma Bank) or GFP (mouse monoclonal 1:500; rabbit
polyclonal 1:1000; Molecular Probes, Eugene, OR). The anti-BrdU antibody
(G3G4) was generated by S. J. Kaufman and was obtained from the Developmental
Studies of Hybridoma Bank maintained by the University of Iowa Dept. Biological
Sciences, Iowa City, IA. Cells were then incubated with Texas Red and/or
Alexa Fluor 488-conjugated secondary antibodies (1:200; Molecular Probes).
Alternatively, they were incubated with a biotinylated secondary antibody (1:200),
then with an avidin-biotin-HRP complex (Vectastain ABC kit, Vector, Burlingame,
CA) and subsequently developed with 3,3-diaminobenzidine (DAB, Sigma) and
H2O2. Controls were performed to confirm primary and secondary antibody
specificity. Some cultures were stained with 4’,6-diamidino-2-phenylindole (DAPI,
Vector Laboratories, Burlingame, CA).
Detection of apoptosis
Cultured cells were fixed for 25 minutes in 4% paraformaldehyde in 0.1 M
phosphate buffer, pH 7.3-7.4. Apoptotic cell death was determined by TdT-mediated
dUTP nick-end labelling (TUNEL) using the Apoptosis Detection System
(Promega, Madison, WI) as described previously (Diaz et al., 1999).
Data analysis
To determine the number of cells expressing a specific antigen, ten random fields
per chamber were counted using a 40 objective and fluorescence filters or bright-
field optics (Zeiss Axioplan microscope). The results are expressed as the number
of cells stained for the antigen per ten fields. In cultures infected with the GFP and
PTEN-GFP expression vectors, the proportions of TuJ1-positive, GFAP-positive or
BrdU-positive cells co-labelled with anti-GFP were calculated with respect to the
total number of GFP-expressing cells. The data obtained in PTEN-GFP- or in
PTEN-C/S-GFP-infected cultures were expressed as a percentage of the data
obtained in GFP infected cultures, which were considered to be 100%. The results
were expressed as the average ± s.e.m. of 4-8 cultures from 2-5 experiments unless
otherwise stated. Statistical analysis was performed using the Student’s t test. The
optical density of the specific immunoblot bands was measured by densitometry
using Quantity One software. The levels of PTEN, P-Akt and P-Erk1/2 were
normalized against levels of actin, Akt1/2 and Erk1/2, respectively.
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